av/sernova--big.svg

COM:SINOVAC

Sinovac Biotech

  • Stock

Last Close

6.47

14/11 21:00

Market Cap

464.94M

Beta: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
72.52M
-
63.10M
12.99%
67.41M
6.84%
72.93M
8.18%
174.35M
139.07%
229.65M
31.72%
246.05M
7.14%
510.62M
107.53%
19.37B
3,694.36%
1.49B
92.30%
448.27M
69.97%
cost of revenue
21.27M
-
16.49M
22.47%
18.43M
11.71%
22.39M
21.54%
20.24M
9.61%
24.72M
22.15%
32.47M
31.33%
67.18M
106.91%
1.07B
1,496.04%
684.46M
36.16%
181.52M
73.48%
gross profit
51.25M
-
46.61M
9.06%
48.99M
5.11%
50.53M
3.15%
154.11M
204.96%
204.93M
32.98%
213.58M
4.22%
443.44M
107.62%
18.30B
4,027.39%
808.30M
95.58%
266.75M
67.00%
selling and marketing expenses
-220K
-
2.64M
-
general and administrative expenses
41.98M
-
176.53M
-
591.17M
234.87%
466.32M
-
selling general and administrative expenses
32.43M
-
34.79M
7.26%
37.44M
7.61%
41.76M
11.55%
87.36M
109.21%
137.00M
56.82%
121.47M
11.34%
176.53M
45.33%
591.17M
234.87%
823.54M
39.31%
468.96M
43.06%
research and development expenses
8.38M
-
11.03M
31.61%
9.49M
13.99%
12.65M
33.28%
20.49M
61.99%
21.91M
6.94%
24.25M
10.70%
48.76M
101.04%
155.04M
217.97%
442.11M
185.16%
344.51M
22.07%
other expenses
263K
-
1.36M
415.59%
73K
94.62%
175K
139.73%
13K
92.57%
321K
2,369.23%
-994K
409.66%
2.34M
335.71%
2.24M
4.31%
3.51M
56.47%
367.13M
10,365.59%
cost and expenses
63.69M
-
62.54M
1.81%
63.66M
1.80%
71.23M
11.88%
128.89M
80.95%
184.26M
42.96%
177.20M
3.83%
294.82M
66.38%
1.82B
517.56%
1.95B
7.30%
994.99M
49.07%
operating expenses
42.42M
-
46.05M
8.55%
45.24M
1.75%
48.84M
7.95%
108.65M
122.47%
159.54M
46.84%
144.73M
9.28%
227.64M
57.29%
748.45M
228.79%
1.27B
69.57%
813.48M
35.90%
interest expense
3.03M
-
3.41M
12.41%
1.92M
43.65%
1.73M
9.95%
1.57M
9.25%
1.07M
31.80%
650K
39.25%
1.45M
123.54%
2.84M
95.18%
1.26M
55.43%
2.26M
78.80%
ebitda
18.11M
-
13.02M
28.07%
11.49M
11.79%
7.94M
30.89%
51.54M
549.15%
52.86M
2.58%
76.58M
44.86%
222.27M
190.24%
17.65B
7,842.45%
188.31M
98.93%
-401.98M
313.46%
operating income
8.74M
-
488K
94.42%
3.72M
662.91%
1.22M
67.26%
45.42M
3,625.76%
45.32M
0.22%
68.56M
51.30%
215.64M
214.52%
17.55B
8,039.92%
31.71M
99.82%
-546.72M
1,823.87%
depreciation and amortization
6.84M
-
8.42M
23.06%
6.51M
22.68%
5.34M
18.03%
4.88M
8.53%
5.14M
5.22%
8.02M
56.13%
6.63M
17.37%
100.43M
1,415.68%
156.60M
55.93%
167.90K
99.89%
total other income expenses net
175K
-
1.28M
632.57%
47K
96.33%
-303K
744.68%
-29K
90.43%
246K
948.28%
2.26M
817.89%
973K
56.91%
9.78M
905.55%
-6.48M
166.20%
393.69M
6,178.28%
income before tax
8.14M
-
1.12M
86.22%
3.03M
170.14%
396K
86.94%
45.04M
11,274.75%
46.58M
3.42%
70.82M
52.03%
216.62M
205.87%
17.56B
8,007.88%
25.24M
99.86%
-153.03M
706.36%
income tax expense
-2.23M
-
1.46M
165.53%
2.52M
72.57%
2.74M
8.82%
8.34M
204.57%
10.47M
25.58%
5.61M
46.48%
31.44M
460.89%
3.10B
9,773.82%
-62.89M
102.03%
105.32M
267.46%
net income
7.44M
-
-851K
111.44%
-1.07M
26.20%
-13K
98.79%
25.81M
198,615.38%
21.78M
15.60%
65.22M
199.40%
185.18M
183.95%
14.46B
7,708.07%
88.13M
99.39%
-99.92M
213.37%
weighted average shs out
55.30M
-
55.68M
0.69%
56.31M
1.14%
56.95M
1.13%
57.03M
0.15%
64.73M
13.49%
94.88M
46.58%
98.90M
4.24%
99.31M
0.42%
99.50M
0.19%
99.61M
0.11%
weighted average shs out dil
55.80M
-
55.68M
0.22%
56.31M
1.14%
56.95M
1.13%
57.10M
0.27%
64.98M
13.79%
109.69M
68.82%
113.66M
3.62%
114.01M
0.30%
114.17M
0.15%
99.61M
12.76%
eps
0.13
-
-0.02
111.77%
-0.02
24.84%
-0.00
98.95%
0.45
225,100%
0.34
24.44%
0.69
102.94%
1.87
171.01%
145.59
7,685.56%
0.89
99.39%
-1
212.36%
epsdiluted
0.13
-
-0.02
111.77%
-0.02
24.84%
-0.00
98.95%
0.45
225,100%
0.34
24.44%
0.59
73.53%
1.63
176.27%
126.83
7,680.98%
0.77
99.39%
-1
229.87%

All numbers in (except ratios and percentages)